Evoq Remedies Profit & Loss Annual

BSE: 543500 | NSE: - | ISIN: INE0JVD01011 | Sector: Biotechnology & Drugs
4.76 -0.09 (-1.86%)Updated : 11 Jul 2025
Fiscal Period2025202420232022
Period End DateMar 25Mar 24Mar 23Mar 22
Total Operating Expense 14.045.7024.1315.32
Other Net 2.412.266.020.00
Diluted Weighted Average Shares 2.211.361.361.36
Depreciation/ Amortization 0.050.010.000.00
Operating Income -2.29-1.65-3.741.46
Net Income 0.090.451.621.09
Income Availableto Com Excl Extra Ord 0.090.451.621.09
Net Income Before Taxes 0.130.612.281.46
Other Operating Expenses Total 0.844.064.591.37
Net Income After Taxes 0.090.451.621.09
Income Availableto Com Incl Extra Ord 0.090.451.621.09
Costof Revenue Total 13.081.5619.3313.77
Gross Profit -1.322.501.063.01
Interest Inc( Exp) Net- Non- Op Total 0.00--0.00
Diluted Net Income 0.090.451.621.09
Provisionfor Income Taxes 0.040.160.670.37
period Type ----
Net Income Before Extra Items 0.090.451.621.09
Total Revenue 11.764.0520.3916.78
period Length 12.0012.0012.0012.00
Revenue 11.764.0520.3916.78
Selling/ General/ Admin Expenses Total 0.070.080.200.18
Diluted Normalized EPS 0.040.331.190.80
Diluted EPS Excluding Extra Ord Items 0.040.331.190.80
Total Adjustmentsto Net Income ---0.00
DPS- Common Stock Primary Issue ---0.00
*All figures in crores except per share values
Recommended For You
Trending Stocks
2,520.10+111.05(4.61%)
1,173.75+9.25(0.79%)
858.70+6.05(0.71%)
3,074.95-86.80 (-2.75%)